Thirty-one of 256 cases of chronic destructive pneumonia who were judged, by the severity of illness and haemoptysis, to have lung gangrene, were managed with intravenous sodium cephalothin. Five patients died, two in relation to emergency pneumonectomy. In comparison with results of management of this disease in previous, similar patients, the results are encouraging.
There is a group of chronic infective destructive pulmonary lesions which may be difficult to distinguish, on clinical and radiological grounds, from peripheral cavitated pulmonary carcinoma and pulmonary tuberculosis, and which, while resembling precisely acute lung abscess radiographically, do not present as an acute illness of short duration. In the majority of patients the conservative management of chronic destructive pulmonary lesions is more or less satisfactory-in most, although there is bronchographic evidence of permanent residual bronchial damage, the abscess cavities diminish in size and residual symptoms are unusual. In a proportion of patients, however, pulmonary destruction is progressive, molar rather than molecular, and haemoptysis is ingravescent and life-threatening. The surgical management of progressive destructive pneumonia is associated with a complication rate so high that any operation other than drainage should be avoided unless it is judged that death from haemoptysis is otherwise certain.
The bacterial flora of chronic cavitated suppurative pneumonia is often mixed and the causative organisms are difficult to isolate. The source of mixed pulmonary infection, which is the cause of some chronic destructive pneumonias, is probably similar to that which results in acute lung abscess -aspiration during sleep, or in periods of unconsciousness related to drunkenness, anaesthesia, epilepsy, suicidal barbiturate narcosis, electroconvulsive therapy, and aspiration in relation to oesophageal obstruction from whatever cause.
There is also no certain evidence that the initial insult is bacterial and not the consequence of pulmonary infarction, although the relative youth of many of the patients and the absence of cause for pulmonary infarction make this unlikely.
The patient with a chronic destructive pneumonia is at risk in many ways-because of the imminent danger of exsanguinating haemoptysis; because of the general and local consequences of a chronic suppurative illness; because the patient may in fact have a carcinoma, treatment of which is delayed for so long that the carcinoma has disseminated; because the patient may be managed as if he had a carcinoma, by pulmonary resection and, in the circumstances outlined, pulmonary resection carries with it an almost prohibitively high rate of postoperative complications; or because the patient has pulmonary tuberculosis. The Three of the 31 patients died from exsanguinating haemoptysis during treatment, one after four days, and two after nine days. In five the abscess cavity continued to increase in size, and drainage by rib resection was undertaken. In four, increasing haemoptysis prompted management by pulmonary resection-in all, by pneumonectomy. Two of these patients died in the early postoperative period from contralateral pulmonary infection, presumably the consequence of intraoperative spill into the opposite bronchial tree. Another patient submitted to pneumonectomy developed an empyema, in the management of which an extensive thoracoplasty was ultimately required. In 18 of the remaining 19 patients improvement in clinical state became recognizable within 72 hours of the beginning of intravenous therapy with cephalothin; haemoptysis and the volume of purulent sputum produced diminished and sputum became mucoid; there was radiographic evidence of diminution in size of the abscess cavity. In all, a stage was reached when the patient's clinical state justified bronchography and in all there was bronchographic evidence of residual bronchiectasis, in most gross and in some more than lobar. In five of these 19 patients, symptoms recurred during a period of observation and management has been by lobectomy; from this procedure all have convalesced uneventfully.
Of the 31 patients, eight (seven Asiatics and one of Caucasian stock) were diabetic and in them pulmonary infection made control of diabetes difficult. Of these eight patients six had proteinuria and in all creatinine clearance was impaired. In the remaining 23 patients there was proteinuria in 10, and in six of these creatinine clearance was also impaired. The reputed dose-dependent nephrotoxicity of cephaloridine prompted the use of sodium cephalothin since it was the aim of therapy to use high dosage, for the reasons previously indicated. The antibacterial spectrum of the two antibiotics is similar. Serum protein binding of cephalothin is considerably greater than of cephaloridine, but the degree of protein binding of cephalothin must be easily reversed since most is rapidly excreted via the kidneys within six hours (Barber and Waterworth, 1964) .
The serum half-life of cephaloridine in patients with normal renal function (12 hours) is approximately three times that of cephalothin. Available evidence (Kabins and Cohen, 1965 ; Kunin and Atuk, 1966; and Ruedy, 1967) (Merrill, Davis, Smolens, and Finegold, 1966; Rahal, Meyers, and Weinstein, 1968 
